-
Albumedix Announces Appointment of Gregor Kawaletz as Chief Commercial Officer
Jun 1, 2020, 11:46 AM by Michael CroftNOTTINGHAM, UNITED KINGDOM - Jun 1, 2020 - Albumedix Ltd. (Albumedix), the world leader in recombinant human albumin (rAlb), announced today the strengthening of its Executive Leadership with the appointment of Gregor Kawaletz as Chief Commercial Officer, as of June 1st, 2020Full story -
Accumen Launches Hospital Lab Crisis Preparedness Program
May 29, 2020, 11:10 AM by Michael CroftPHOENIX, AZ - May 29, 2020 - Accumen Inc. is helping healthcare get better, faster. As an extension of its ongoing effort to provide resources that enable hospitals to manage every phase of the COVID-19 pandemic optimally, today Accumen launched its Lab Crisis Preparedness Program to help hospitals ensure their laboratories are able to meet the testing needs of their health system and surrounding communitiesFull story -
Long-Term Follow Up Data from Groundbreaking MINDACT Study Continues to Demonstrate Clinical Utility of MammaPrint®
May 29, 2020, 08:27 AM by Michael CroftIRVINE, CALIF., U.S., AND AMSTERDAM, NETHERLANDS - May 29, 2020 - Agendia, Inc., a world leader in precision oncology for breast cancer, today announced new data from MINDACT, the prospective randomized trial designed to further demonstrate the clinical utility of MammaPrint® risk scoring when determining a breast cancer patients need for chemotherapyFull story -
Shivom Launches FREE Informatics – Secure Health Data Sharing Solutions to Organisations Studying COVID-19.
May 29, 2020, 07:54 AM by Michael CroftLONDON, UNITED KINGDOM - May 29, 2020 - Shivom Ventures Limited Shivom today announced the startup will be playing its part in combating the deadly coronavirus disease by offering researchers and pharmaceutical companies a 1-year free subscription to interrogate both viral and human genomes separately from RAW sequencing dataFull story -
Studies Suggest COVID-19 Could Become Seasonal Virus, Other News
May 29, 2020, 07:25 AM by Michael CroftFull storyBio-IT World | A review of coronavirus immunity studies suggest the COVID-19 virus could become the fifth seasonal coronavirus with recurring epidemics of lessening severity over the next several years. Over 200 SARS-CoV-2 genome sequences have now been completed and released. We round up the week’s research and industry news for COVID-19.
-
BOC Sciences Adds Featured SARS-CoV-2 Inhibitors for Drug Discovery
May 28, 2020, 22:44 PM by Michael CroftSHIRLEY, NY, UNITED STATES - May 29, 2020 - In recent days, BOC Sciences, one of the world’s leading chemical and pharmaceutical provider, announced to add more than 100 inhibitors of SARS-CoV-2 to its present inhibitor base to help the drug discovery of scientific research institutions during the COVID-19 pandemicFull story -
Elucid Digital Health reduces smart Pill Connect bottle to a smart cap dispenser which can fit on any medicine bottle
May 28, 2020, 12:46 PM by Michael CroftMANCHESTER, UNITED KINGDOM - May 28, 2020 -Full story- The Elucid Digital Health screw on dispenser cap + app prompts compliance, messages patients, records temperature and humidity and provides real time reports for doctors or monitors
- Compliance in clinical trials is a serious problem with patients failing to comply - deteriorating as the trial progresses
- Non-compliance is estimated by the OECD to cause 200,000 premature deaths in Europe and estimated to cost E 125 billion in EU $105 billion in the US annually in avoidable hospitalisations, emergency care, and outpatient visitsx
-
CD Genomics Launches NGS Panels for SARS-CoV-2 Detection and Research
May 28, 2020, 10:26 AM by Michael CroftSHIRLEY, NY, UNITED STATES - May 20, 2020 - CD Genomics has developed a very comprehensive NGS panels for sequencing, coronaviruses detection, phylogenetic analysis and molecular characterization of the 2019 novel coronavirus (namely SARS-CoV-2, and the virus is responsible for COVID-19)Full story -
ERT helps medical researchers accelerate clinical trials with AI-assistance from Dynatrace
May 28, 2020, 08:15 AM by Michael CroftWALTHAM, MA, UNITED STATES - May 28, 2020 - Software intelligence company Dynatrace (NYSE: DT), today announced that ERT – a developer of software and devices used by medical researchers in 75% of FDA approved clinical trials in 2019 – is using Dynatrace® to automate DevOps processes, and speed up delivery of new applications, from an average of six weeks to as little as two weeksFull story -
Intel, Penn Medicine Launch Federated Learning Model For Brain Tumors
May 28, 2020, 08:10 AM by Michael CroftFull storyBio-IT World | The University of Pennsylvania and Intel have built a federation of 30 institutions to use federated learning to train artificial intelligence models to identify boundaries of brain tumors.
-
Alfa Chemistry Testing Lab Releases Nano-products Safety Evaluation Services
May 28, 2020, 01:59 AM by Michael CroftNEW YORK, NY, UNITED STATES - May 28, 2020 - Earlier this month in May, 2020, Alfa Chemistry Testing Lab, a professional testing and analysis organization, announced to have released nano-products safety evaluation services for companies and agencies that are engaged with the development and application of nano-productsFull story -
Research at MDI Biological Laboratory Explores Novel Pathways of Regeneration and Tumorigenesis
May 27, 2020, 16:22 PM by Michael CroftBAR HARBOR, ME, UNITED STATES - May 27, 2020 - Research by scientists at the MDI Biological Laboratory in Bar Harbor, Maine, is opening up new approaches to promoting tissue regeneration in organs damaged by disease or injuryFull story -
Benchling, BERG, Thermo Fisher Scientific, And More: News From May 2020
May 27, 2020, 10:40 AM by Michael CroftFull storyBio-IT World May featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Benchling, BERG, Thermo Fisher Scientific, and more.
-
Biodesy Announces Corporate Name Change to BlueLight Therapeutics
May 27, 2020, 09:44 AM by Michael CroftSOUTH SAN FRANCISCO, CA, UNITED STATES - May 27, 2020 - Biodesy Inc. today announced that it has changed its corporate name to BlueLight Therapeutics Inc., effective May 20, 2020, and appointed drug discovery expert Mark Gallop, PhD, as Chief Scientific OfficerFull story -
AI & Medicine — An Expert in AI-aided Drug Discovery and Medical Applications
May 27, 2020, 03:54 AM by Michael CroftNEW YORK, NY, UNITED STATES - May 27, 2020 - Recently founded, the New York-based company AI & Medicine is an expert in the field of AI-Powered drug discovery, personalized healthcare and various medical applicationsFull story -
Alfa Chemistry Offers PEG linkers for the Science Community in Bioconjugation and Pegylation
May 27, 2020, 03:48 AM by Michael CroftNEW YORK, NY, UNITED STATES - May 27, 2020 - Earlier this month in May, 2020, the world's leading chemical supplier Alfa Chemistry announced that a total of close to 800 PEG linker products are now available for its customers worldwide, including acid PEG linkers, alkyl PEG linkers, amino PEG linkers, azido PEG linkers, benzyl PEG linkers, biotin PEG linkers, fmoc PEG linkers, NHBoc PEG linkers, NHS ester PEG linkers, t-butyl ester PEG linkers, THP PEG linkers, and other PEG LinkersFull story -
2bPrecise Solution Wins 2020 MedTech Breakthrough Award
May 26, 2020, 12:09 PM by Michael CroftPITTSBURGH, PA, UNITED STATES - May 26, 2020 - 2bPrecise, an EHR-agnostic, cloud-based precision medicine platform, has been recognized as the Best Overall Genomics Solution in the fourth annual MedTech Breakthrough Awards programFull story -
ALBUMEDIX ANNOUNCE JONAS SKJØDT MØLLER AS NEW CHIEF EXECUTIVE OFFICER
May 26, 2020, 10:39 AM by Michael CroftNOTTINGHAM, ENGLAND - May 26, 2020 - Albumedix Ltd. (Albumedix), the world leader in recombinant human albumin (rAlb), announced today its succession plan as Peter Rosholm, after 13 years leading the company, has decided to step down as CEO and handover the companys leadershipFull story -
Successful partnership between MolPort and BioAscent reaches 100-project milestone
May 26, 2020, 09:09 AM by Michael CroftBEACON, NY - May 26, 2020 - Successful partnership between MolPort and BioAscent reaches 100-project milestonePartnership enhances customer service and simplifies logistics of compound sourcing for scientists MolPort IncFull story -
EchelonDx Launches Mobile COVID-19 Testing and Vaccination Verification Application to Help Reopen Local Businesses, Restore Employment and Revive Economic Growth
May 26, 2020, 09:01 AM by Michael CroftRENO, NV, UNITED STATES - May 26, 2020 - Echelon Diagnostics, Inc., a leading provider of genomic healthcare AI imaging and big data solutions, today announced the commercial launch of the SafeKey Health Passport (Patent Pending)Full story